Synovics Pharmaceuticals
SYVC · OTC
$0.0001+$0.0001 (+9900.00%)TodayMarket closed ·
No price history for this range.
Key indicators
SYVC profitability and balance sheet ratios
EPS -$0.0676 in Jul 2009, down 493.0% on a year earlier.
| Period | EPS |
|---|---|
| Oct 2007 | -$0.1672 |
| Jan 2008 | -$0.0943 |
| Apr 2008 | -$0.1393 |
| Jul 2008 | $0.0172 |
| Oct 2008 | $0.0263 |
| Jan 2009 | -$0.0388 |
| Apr 2009 | -$0.0905 |
| Jul 2009 | -$0.0676 |
Income statement
No financial statements are reported for Synovics Pharmaceuticals.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Jan 2009 | Apr 2009 | Jul 2009 |
|---|---|---|---|
| Total assets | $21.8M | $19.4M | $18.8M |
| Total liabilities | $17.7M | $18.1M | $19.5M |
| Shareholder equity | $4.0M | $1.3M | −$0.8M |
| Cash and short-term investments | $0.0M | $0.0M | $0.1M |
| Total debt | $6.1M | $6.0M | $6.1M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.